Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) EPS (Weighted Average and Diluted) (2018 - 2025)

Historic EPS (Weighted Average and Diluted) for Organogenesis Holdings (ORGO) over the last 8 years, with Q3 2025 value amounting to $0.11.

  • Organogenesis Holdings' EPS (Weighted Average and Diluted) rose 2222.22% to $0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.12, marking a year-over-year decrease of 10000.0%. This contributed to the annual value of -$0.01 for FY2024, which is 11779.02% down from last year.
  • Latest data reveals that Organogenesis Holdings reported EPS (Weighted Average and Diluted) of $0.11 as of Q3 2025, which was up 2222.22% from -$0.09 recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' EPS (Weighted Average and Diluted) peaked at $0.38 during Q4 2021, and registered a low of -$0.17 during Q1 2025.
  • In the last 5 years, Organogenesis Holdings' EPS (Weighted Average and Diluted) had a median value of $0.04 in 2023 and averaged $0.04.
  • As far as peak fluctuations go, Organogenesis Holdings' EPS (Weighted Average and Diluted) skyrocketed by 114276.32% in 2024, and later plummeted by 75000.0% in 2025.
  • Over the past 5 years, Organogenesis Holdings' EPS (Weighted Average and Diluted) (Quarter) stood at $0.38 in 2021, then crashed by 84.21% to $0.06 in 2022, then plummeted by 107.13% to -$0.0 in 2023, then soared by 1142.76% to $0.04 in 2024, then surged by 146.54% to $0.11 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.11 in Q3 2025, compared to -$0.09 in Q2 2025 and -$0.17 in Q1 2025.